These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9865363)

  • 1. Ischemia reperfusion injury and chronic allograft rejection.
    Szabo A; Heemann U
    Transplant Proc; 1998 Dec; 30(8):4281-4. PubMed ID: 9865363
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic graft loss: dealing with the vascular alterations in solid organ transplantation.
    Cook NS; Zerwes HG; Rudin M; Beckmann N; Schuurman HJ
    Transplant Proc; 1998 Aug; 30(5):2413-8. PubMed ID: 9723522
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigen-independent events mimic characteristic changes of chronic allograft rejection.
    Tullius SG; Heemann UW; Azuma H; Hancock WW; Pradham P; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):561-3. PubMed ID: 7879099
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic allograft rejection: an update.
    Häyry P; Yilmaz S
    Transplant Proc; 1994 Dec; 26(6):3159-60. PubMed ID: 7998102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic allograft destruction vs chronic allograft rejection.
    Jacobs U; Brensing KA; Klehr HU
    Transplant Proc; 1994 Dec; 26(6):3119-20. PubMed ID: 7998087
    [No Abstract]   [Full Text] [Related]  

  • 7. Postischemic reperfusion injury and allograft arteriosclerosis.
    Fellström B; Aküyrek LM; Backman U; Larsson E; Melin J; Zezina L
    Transplant Proc; 1998 Dec; 30(8):4278-80. PubMed ID: 9865362
    [No Abstract]   [Full Text] [Related]  

  • 8. Cells, cytokines, adhesion molecules, and humoral responses in a rat model of chronic renal allograft rejection.
    Hancock WW; Whitley WD; Baldwin WM; Tilney NL
    Transplant Proc; 1992 Oct; 24(5):2315-6. PubMed ID: 1413075
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic allograft nephropathy--immunologic and nonimmunologic factors.
    Banasik M; Klinger M
    Ann Transplant; 2006; 11(1):7-10. PubMed ID: 17025023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation.
    Land W
    Transplant Proc; 1994 Dec; 26(6):3169-71. PubMed ID: 7998106
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute rejection of rat renal allografts is influenced by the presence of a native kidney.
    Grau V; Herbst B; Steiniger B
    Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acute damage from acute rejection and ischemia on long-term renal allograft histology.
    Dennis MJ; Beckingham IJ; Blamey RW
    Transplant Proc; 1993 Apr; 25(2):2101. PubMed ID: 8470284
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunobiology and pathology of chronic rejection.
    Häyry P; Myllärniemi M; Calderon Ramirez L; Aavik E; Loubtchenkov M; Koskinen P; Lemström K; Räisänen-Sokolowski A
    Transplant Proc; 1997; 29(1-2):77-8. PubMed ID: 9123163
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
    Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between duodenal and kidney rejection: a histologic comparative study in a pig model of pancreaticoduodenal-kidney transplantation.
    Gruessner RW; Nakhleh R; Tzardis PJ; Schechner R; Troppmann C; Gruessner AC; Najarian JS; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):541-3. PubMed ID: 8171544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent review of renal allograft pathology].
    Yamaguchi Y
    Nihon Jinzo Gakkai Shi; 2005; 47(1):26-31. PubMed ID: 15754760
    [No Abstract]   [Full Text] [Related]  

  • 17. Protocol core biopsy (CADI): a surrogate marker for chronic rejection. Mycophenolate Mofetil ICM 1866 and IICR 023 Study Groups.
    Yilmaz S; Taskinen E; Paavonen T; Häyry P
    Transplant Proc; 2000 Feb; 32(1A Suppl):12S. PubMed ID: 10686312
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapeutic approach to prevent or treat chronic allograft nephropathy.
    Scholten EM; de Fijter JW; Paul LC
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Dec; 2(2):79-96. PubMed ID: 12769650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction.
    Bedi DS; Riella LV; Tullius SG; Chandraker A
    Transplantation; 2010 Nov; 90(9):935-44. PubMed ID: 20703180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of free radical-mediated reperfusion injury on acute and chronic rejection events following cadaveric renal transplantation.
    Schneeberger H; Schleibner S; Illner WD; Messmer K; Land W
    Clin Transpl; 1993; ():219-32. PubMed ID: 7918155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.